The ANZCTR website will be unavailable from 1-2pm (AEST) on Thursday 22nd May for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619000124134
Ethics application status
Approved
Date submitted
20/12/2018
Date registered
29/01/2019
Date last updated
29/01/2019
Date data sharing statement initially provided
29/01/2019
Date results provided
29/01/2019
Type of registration
Retrospectively registered

Titles & IDs
Public title
Common ground impedance as a biomarker for post operative hearing loss and dizziness in cochlear implant recipients
Scientific title
Common ground impedance as a biomarker for post operative hearing loss and dizziness in cochlear implant recipients
Secondary ID [1] 296924 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Hearing Loss 310875 0
Condition category
Condition code
Ear 309549 309549 0 0
Deafness

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Hearing loss after cochlear implantation can occur immediately after surgery, or up to 5 years after implantation. Spikes in common ground impedance, i.e., increases in electrode resistivity of greater than 4 kOs, have been associated with a loss of residual hearing and the development of post-operative dizziness in cochlear implant recipients. In this study, we will observe impedances across the electrode array, and associated any spikes observed with medical events. Impedance measurements are routinely recorded by cochlear implant audiologists during patient visits to a clinic, therefore these observations are made immediately after implantation, then at 1, 2, 4, and 8 weeks post-implantation, and every 3-6 months thereafter for a total duration of up to 5 years. Medical events will be recorded by the cochlear implant clinic medical staff.
Intervention code [1] 313195 0
Not applicable
Comparator / control treatment
No control
Control group
Uncontrolled

Outcomes
Primary outcome [1] 318501 0
Primary outcome 1: Median change in hearing level, assessed by pure tone audiometry measured by a qualified audiologist
Timepoint [1] 318501 0
Timepoint: Measured at 1, 2, 4, 8 weeks after implantation, and at any further visits to the audiology clinic.
Secondary outcome [1] 365171 0
Secondary outcome 1: Development of clinically defined dizziness, vertigo or imbalance, assessed by a medical professional administering the Dizziness Handicap Inventory (DHI) questionnaire.
Timepoint [1] 365171 0
Timepoint: Measured at 1, 2, 4, 8 weeks after implantation, and at any further visits to the audiology clinic.

Eligibility
Key inclusion criteria
Any adult capable of participating with an audiogram, in whom a clinical recommendation has been made to receive a cochlear implant.
Receiving a slim-straight Cochlear CI522 electrode array.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Deafness due to cochlear malformations, including ossification, confirmed by medical examination
Pre-existing cochlear implantation
Any medical condition contraindicating the use of dexamethasone post-operatively.

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis
Non parametric comparison of hearing level and dizziness in elevated impedance and low impedance groups

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 301498 0
Commercial sector/Industry
Name [1] 301498 0
COCHLEAR LTD
Country [1] 301498 0
Australia
Primary sponsor type
University
Name
University of Melbourne
Country
Australia
Secondary sponsor category [1] 301191 0
None
Name [1] 301191 0
none
Country [1] 301191 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 302238 0
'The Royal Victorian Eye & Ear Hospital Human Research & Ethics Committee'
Ethics committee address [1] 302238 0
Ethics committee country [1] 302238 0
Australia
Date submitted for ethics approval [1] 302238 0
Approval date [1] 302238 0
01/02/2016
Ethics approval number [1] 302238 0

Summary
Brief summary
Trial website
Public notes

Contacts
Principal investigator
Name 89550 0
Prof Stephen O'leary
Address 89550 0
The University of Melbourne, Department of Otolaryngology Level 5, Peter Howsen Wing, Gisborne Street East Melbourne 3002, Victoria
Country 89550 0
Australia
Phone 89550 0
+61 3 9929 8366
Fax 89550 0
Email 89550 0
sjoleary@unimelb.edu.au
Contact person for public queries
Name 89551 0
Christo bester
Address 89551 0
The University of Melbourne, Department of Otolaryngology Level 5, Peter Howsen Wing, Gisborne Street East Melbourne 3002, Victoria
Country 89551 0
Australia
Phone 89551 0
+61 399298485
Fax 89551 0
Email 89551 0
christofer.bester@unimelb.edu.au
Contact person for scientific queries
Name 89552 0
Christo bester
Address 89552 0
The University of Melbourne, Department of Otolaryngology Level 5, Peter Howsen Wing, Gisborne Street East Melbourne 3002, Victoria
Country 89552 0
Australia
Phone 89552 0
+61 399298485
Fax 89552 0
Email 89552 0
christofer.bester@unimelb.edu.au

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
Open Access

Conditions for requesting access:
-

What individual participant data might be shared?
Data immediately relevant to the primary and secondary outcomes, in a non-identifiable format

What types of analyses could be done with individual participant data?
Any

When can requests for individual participant data be made (start and end dates)?
From:
At the completion of the study.
At present the dates are not confirmed. Will update as soon as it is confirmed


To:
-

Where can requests to access individual participant data be made, or data be obtained directly?
Open Access data storage

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.